Creatine supplementation increases ATP levels in dendritic cells derived from mice and humans, which enhances their capacity to activate T cells to recognize tumor antigens.
See the scientific wording
Creatine supplementation enhances the activation and metabolic function of dendritic cells in mouse tumor models and human monocyte-derived dendritic cells in vitro, increasing intracellular ATP levels and improving their ability to stimulate T cell responses against tumor antigens.
Correlational — new studies may shift this
ObservationalOne low-scoring study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
Cohort StudyHuman
Creatine, a supplement people take to get stronger, also helps immune cells in the body work better to find and fight cancer by giving them more energy. This was shown in both mice and human cells in the lab.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Dendritic cells take up creatine from their environment, convert it into a high-energy molecule that maintains ATP levels, and use that energy to become fully active, display tumor signals more effectively, and strongly activate T cells to kill cancer cells.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Creatine supplementation increases ATP levels in dendritic cells derived from mice and humans, which enhances their capacity to activate T cells to recognize tumor antigens.
Mechanism
1 studyDendritic cells pull in creatine to keep their energy supply high, which lets them properly show cancer signals to T cells. With more energy, dendritic cells activate T cells more strongly, and those T cells then hunt down and destroy tumor cells.
Dendritic cells take up creatine from their environment, convert it into a high-energy molecule that maintains ATP levels, and use that energy to become fully active, display tumor signals more effectively, and strongly activate T cells to kill cancer cells.
Dendritic cells in tumor environments increase expression of the creatine transporter SLC6A8 to import creatine from the extracellular space
Internalized creatine is phosphorylated to phosphocreatine, which rapidly regenerates ATP during periods of high energy demand
Elevated ATP sustains energy-intensive processes including antigen processing, upregulation of co-stimulatory molecules, and secretion of inflammatory cytokines
Activated dendritic cells present tumor antigens more effectively and deliver stronger co-stimulatory signals to T cells
T cells receive enhanced activation signals, leading to increased proliferation, production of cytotoxic cytokines, and direct killing of tumor cells
Evidence from Studies
Supporting (1)
Community contributions welcome
Unknown Title
Creatine, a supplement people take to get stronger, also helps immune cells in the body work better to find and fight cancer by giving them more energy. This was shown in both mice and human cells in the lab.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Creatine Supplementation Effects on Dendritic Cell Activation and T Cell Stimulation in Cancer Models
Systematic review and meta-analysis of all published in vitro and animal studies comparing creatine-supplemented versus control dendritic cells, measuring ATP levels and T cell activation against tumor antigens
Double-Blind RCT of Creatine Supplementation on Human Monocyte-Derived Dendritic Cell Function in Cancer Patients
Double-blind, placebo-controlled trial in cancer patients comparing oral creatine supplementation versus placebo, measuring ATP levels and T cell activation capacity in isolated monocyte-derived dendritic cells before and after 8 weeks of intervention
Prospective Cohort Study of Creatine Supplement Use and Dendritic Cell Function in Cancer Patients
Prospective cohort study following cancer patients who self-report creatine use versus those who do not, measuring dendritic cell ATP levels and T cell activation at baseline and 12 weeks
In Vitro Study of Creatine on ATP Levels and T Cell Stimulation in Human Monocyte-Derived Dendritic Cells
In vitro exposure of human monocyte-derived dendritic cells to creatine at varying concentrations (e.g., 0.1–10 mM) for 24–72 hours, measuring ATP levels and co-culture T cell proliferation and cytokine production
Mouse Tumor Model Study of Creatine Supplementation on Dendritic Cell Activation and Tumor Immunity
Mouse tumor model (e.g., melanoma or colon carcinoma) with oral creatine supplementation versus control, measuring tumor growth, dendritic cell ATP levels, and tumor-infiltrating T cell responses over 4–6 weeks